We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Boosting the Efficacy of A Key Cancer Treatment

News   Feb 21, 2017 | Original story from Sbarro Health Research Organization

 
Boosting the Efficacy of A Key Cancer Treatment

MicroRNA-125a-5p is a downstream effector of sorafenib in its antiproliferative activity toward human hepatocellular carcinoma cells. Credit: Sbarro Health Research Organization

 
 
Advertisement
 

RELATED ARTICLES

Avoiding Side Effects Associated With Cancer Treatment

News

Researchers at the University of California, Irvine and Switzerland's Lausanne University Hospital/University of Luassanne (CHUV/UNIL) may have found a way to treat cancer without the onset of debilitating side effects.

READ MORE

New Tactic To Stop the Growth of Glioblastoma

News

Scientists have discovered a way to halt the growth of glioblastoma, a deadly brain cancer. The team has devised a new tactic in the war against cancer that involves reprogramming the immune system to fight the tumor, rather than fueling it.

READ MORE

Cancer Remodels the Architecture of Chromosomes to Its Advantage

News

Cancer remodels the architecture of our chromosomes so the disease can take hold and metastasize.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE